TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Condition: Lymphoblastic Leukemia Interventions: Drug: Dexamethasone; Drug: Mitoxantrone; Drug: PEG asparaginase; Drug: Bortezomib; Drug: Vorinostat; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Blinatumomab; Drug: Ziftomenib Sponsors: Stanford University; Pediatric Oncology Experimental Therapeutics Investigators' Consortium; Amgen; Lucile Packard Children's Hospital Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials